Search for a command to run...
No recent news available for this stock.
Solara Active Pharma Sciences Ltd. is underperforming compared to its peers across key financial metrics, particularly in revenue growth and profitability. Companies like Sun Pharmaceutical and Cipla showcase strong growth and efficiency, making them sector leaders, while Solara's high PE ratio and negative profitability margins indicate overvaluation and financial stress.
Highest revenue growth and profitability metrics in the sector.
Strong growth with a low PE ratio and high ROE.
Excellent revenue growth and profitability, coupled with a low debt ratio.